Atom Investors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Atom Investors’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-75,434	Closed	-$2.09M	–	582
2025 Q3	$2.09M	Buy	75,434 +7,112	+10%	+$180K	0.16%	162
2025 Q2	$1.66M	Sell	68,322 -12,742	-16%	-$279K	0.15%	184
2025 Q1	$1.68M	Buy	81,064 +19,631	+32%	+$493K	0.21%	140
2024 Q4	$1.45M	Buy	61,433 +12,302	+25%	+$303K	0.18%	165
2024 Q3	$1.26M	Buy	49,131 +6,496	+15%	+$165K	0.13%	220
2024 Q2	$1M	Buy	+42,635	New	+$1.08M	0.1%	250

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Atom Investors's ARKG Position: Q4 2025 in Review

Atom Investors sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 75,434 shares — an estimated $2.09M sold.

Atom Investors first reported a position in ARKG in Q2 2024 and held it in 6 quarters. The position peaked at $2.09M in Q3 2025. 238 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.

Atom Investors reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
Atom Investors sold 75,434 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $2.09M.
Atom Investors first reported a position in ARK Genomic Revolution ETF in Q2 2024 and held it in 6 quarters.
Atom Investors's ARK Genomic Revolution ETF position peaked at $2.09M in Q3 2025.
238 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.

Based on Atom Investors's 13F filing for Q4 2025, filed 17 Feb 2026.